232 related articles for article (PubMed ID: 26179634)
1. Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review.
Watanabe R; Ishii T; Yoshida M; Takada N; Yokokura S; Shirota Y; Fujii H; Harigae H
Int J Rheum Dis; 2017 Feb; 20(2):225-230. PubMed ID: 26179634
[TBL] [Abstract][Full Text] [Related]
2. Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era.
Caimmi C; Crowson CS; Smith WM; Matteson EL; Makol A
J Rheumatol; 2018 May; 45(5):595-603. PubMed ID: 29449499
[TBL] [Abstract][Full Text] [Related]
3. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.
Pamuk ÖN; Kalyoncu U; Aksu K; Omma A; Pehlivan Y; Çağatay Y; Küçükşahin O; Dönmez S; Çetin GY; Mercan R; Bayındır Ö; Çefle A; Yıldız F; Balkarlı A; Kılıç L; Çakır N; Kısacık B; Öksüz MF; Çobankara V; Onat AM; Sayarlıoğlu M; Öztürk MA; Pamuk GE; Akkoç N
Rheumatol Int; 2016 Jul; 36(7):945-53. PubMed ID: 27221456
[TBL] [Abstract][Full Text] [Related]
4. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
[TBL] [Abstract][Full Text] [Related]
5. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
6. A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in Australian rheumatology practice.
Nicholls D; Zochling J; Boers A; Champion G; Mathers D; Riordan J; Youssef P; Scott J; Griffiths H
Int J Rheum Dis; 2014 Sep; 17(7):755-61. PubMed ID: 24131467
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.
Sung YK; Cho SK; Kim D; Won S; Choi CB; Bang SY; Hong SJ; Kim HA; Koh EM; Lee HS; Suh CH; Yoo DH; Bae SC
Rheumatol Int; 2017 Jun; 37(6):1007-1014. PubMed ID: 28214924
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and Treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population.
Crane MM; Juneja M; Allen J; Kurrasch RH; Chu ME; Quattrocchi E; Manson SC; Chang DJ
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1646-55. PubMed ID: 26097059
[TBL] [Abstract][Full Text] [Related]
9. Necrotising Scleritis and Peripheral Ulcerative Keratitis Associated with Rheumatoid Arthritis Treated with Rituximab.
Hardy S; Hashemi K; Catanese M; Candil M; Zufferey P; Gabison E; Guex-Crosier Y
Klin Monbl Augenheilkd; 2017 Apr; 234(4):567-570. PubMed ID: 28147401
[No Abstract] [Full Text] [Related]
10. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
11. Risk of tuberculosis, serious infection and lymphoma with disease-modifying biologic drugs in rheumatoid arthritis patients in Taiwan.
Chiu YM; Lang HC; Lin HY; Yang MT; Fang CH; Yang YW; Schabert VF; Tang B
Int J Rheum Dis; 2014 Dec; 17 Suppl 3():9-19. PubMed ID: 25496045
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis.
Sung YK; Cho SK; Kim D; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim HA; Kim J; Kim SK; Kim TH; Lee HS; Lee J; Lee J; Lee SS; Lee SW; Lee YA; Nah SS; Suh CH; Yoo DH; Yoon BY; Bae SC;
Rheumatol Int; 2017 Jun; 37(6):975-982. PubMed ID: 28132102
[TBL] [Abstract][Full Text] [Related]
13. Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions.
Abasolo L; Leon L; Rodriguez-Rodriguez L; Tobias A; Rosales Z; Maria Leal J; Castaño V; Vadillo C; Macarron P; Fontsere O; Jover JA
Semin Arthritis Rheum; 2015 Apr; 44(5):506-513. PubMed ID: 25532946
[TBL] [Abstract][Full Text] [Related]
14. [Necrotizing keratitis in chronic polyarthritis. Combined immunosuppressive and surgical therapy].
Wiezorrek R; Bialasiewicz AA; Engelmann K; Grasedyck K; Richard G
Ophthalmologe; 1998 Sep; 95(9):619-24. PubMed ID: 9793383
[TBL] [Abstract][Full Text] [Related]
15. Effect of tumour necrosis factor-alpha inhibitors on renal function in patients with rheumatoid arthritis from the KOBIO registry from 2012 to 2016.
Kim SK; Choe JY; Kwak SG; Bae J; Park SH; Lee H
Clin Exp Rheumatol; 2018; 36(6):1022-1030. PubMed ID: 29652655
[TBL] [Abstract][Full Text] [Related]
16. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice.
Catay E; Bravo M; Rosa J; Soriano ER
BMC Musculoskelet Disord; 2016 Mar; 17():110. PubMed ID: 26932312
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
Nakamura J; Nagashima T; Nagatani K; Yoshio T; Iwamoto M; Minota S
Int J Rheum Dis; 2016 May; 19(5):470-5. PubMed ID: 24698305
[TBL] [Abstract][Full Text] [Related]
19. [Rituximab in rheumatoid arthritis-associated peripheral ulcerative keratitis].
Albert M; Beltrán E; Martínez-Costa L
Arch Soc Esp Oftalmol; 2011 Apr; 86(4):118-20. PubMed ID: 21569921
[TBL] [Abstract][Full Text] [Related]
20. Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?
Levesque MC
BioDrugs; 2012 Apr; 26(2):65-70. PubMed ID: 22385403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
